The 'EpiEnlist' project: A dermo-epidemiologic study on a representative sample of young Italian males. Prevalence of selected pigmentary lesions

Journal of the European Academy of Dermatology and Venereology

Volumn 21, Issue 8, 2007, Pages 1091-1096

  Ingordo, Vito ^a   Gentile, C ^b   Iannazzone, S S ^c   Cusano, F ^c   Naldi, L ^d  

^a Italian Navy Main Hospital 'G Venticinque'   (Italy)

^b Draft's Council Medical Unit   (Italy)

^c G RUMMO HOSPITAL   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

Becker nevus; Congenital melanocytic nevus; Italian male population; Neurofibromatosis type 1; Prevalence; Vitiligo

Indexed keywords

SMOOTH MUSCLE ANTIBODY; THYROID ANTIBODY;

ADULT; ANAMNESIS; ANTIBODY DETECTION; ARTICLE; BECKER NEVUS; BLOOD ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; HUMAN; ITALY; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; NEUROFIBROMATOSIS; PIGMENT DISORDER; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; THYROID DISEASE; VITILIGO;

ADOLESCENT; DERMOSCOPY; HUMANS; INCIDENCE; ITALY; MALE; MASS SCREENING; MILITARY PERSONNEL; PIGMENTATION DISORDERS; PREVALENCE;

EID: 34548171214     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02205.x     Document Type: Article

References (53)

1. Riccardi VM. Neurofibromatosis: Clinical heterogeneity. Curr Probl Cancer 1982; 7: 1-34.
2. Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 1988; 45: 575-578.
3. Ingordo V, Iannazzone SS, Cusano F, Naldi L. Dermoscopic features of congenital melanocytic nevus and Becker nevus in an adult male population: An analysis with a 10-fold magnification. Dermatology 2006; 212: 354-360.
4. Sergeyev AS. On the mutation rate of neurofibromatosis. Humangenetik 1975; 28: 129-138.
5. Samuelsson B, Axelsson R. Neurofibromatosis. a clinical and genetic study of 96 cases in Gothenburg, Sweden. Acta Derm Venereol Suppl (Stockh) 1981; 95: 67-71.
6. Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989; 26: 704-711.
7. Fuller LC, Cox B, Gardner RJM. Prevalence of von Recklinghausen neurofibromatosis in Dunedin, New Zealand. Neurofibromatosis 1989; 2: 278-283.
8. Garty BZ, Laor A, Danon YL. Neurofibromatosis type 1 in Israel: Survey of young adults. J Med Genet 1994; 31: 853-857.
9. Ingordo V, D'Andria G, Mendicini S, Grecucci S, Baglivo A. Segmental neurofibromatosis: Is it uncommon or under diagnosed? Arch Dermatol 1995; 131: 959-960.
10. Fazii P, Passamonti M, Lappa G, Di Mascio R, Ballone E. Prevalence of neurofibromatosis type 1 among the young adult population of central Italy. Arch Dermatol 1998; 134: 1303-1304.
11. Lammert M, Friedman JM, Kluwe L, Mautner VF. Prevalence of neurofibromatosis 1 in German children at elementary school enrollment. Arch Dermatol 2005; 141: 71-74.
12. Ragge NK, Falk RE, Cohen WE, Murphree AL. Images of Lisch nodules across the spectrum. Eye 1993; 7: 95-101.
13. Nichols JC, Amato JE, Chung SM. Characteristics of Lisch nodules in patients with neurofibromatosis type 1. J Pediatr Ophthalmol Strabismus 2003; 40: 293-296.
14. Tymen R, Forestier JF, Boutet B, Colomb D. Naevus tardif de Becker. A propos d'une série de 100 observations. Ann Dermatol Venereol (Paris) 1981; 108: 41-46.
15. McLean DI, Gallagher RP. 'Sunburn' freckles, café-au-lait macules, and other pigmented lesions of schoolchildren: The Vancouver Mole Study. J Am Acad Dermatol 1995; 32: 565-570.
16. Copeman PWM, Jones EW. Pigmented hairy epidermal nevus (Becker). Arch Dermat 1965; 92: 249-251.
17. Atherton DJ. Becker's naevus. In: Champion RH, Burton JL, Burns DA, Breathnach SM, eds. Textbook of Dermatology Rook/Wilkinson/Ebling, 6th edn, Vol. 1. Blackwell Science, Oxford, 1998: 542-543.
18. Walton RG, Jacobs AH, Cox AJ. Pigmented lesions in newborn infants. Br J Dermatol 1976; 95: 389-396.
19. Alper J, Holmes LB. The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol 1983; 1: 58-78.
20. Osburn K, Schosser RH, Everett MA. Congenital pigmented and vascular lesions in newborn infants. J Am Acad Dermatol 1987; 16: 788-792.
21. Castilla EE, da Graca Dutra MG, Orioli-Parreiras IM. Epidemiology of congenital pigmented nevi 1: Incidence rates and relative frequencies. Br J Dermatol 1981; 104: 307-314.
22. Karvonen SL, Vaajalahti P, Marenk M, Janas M, Kuokkanen K. Birthmarks in 4346 Finnish newborns. Acta Derm Venereol 1992; 72: 55-57.
23. Plantin P, Delaire P, Gavanou J, Boog G, Guillet G. Benign cutaneous lesions observed within the 1st 48 hours of life in 874 infants born at a maternity ward of a University hospital. Apropos of 148 cases. Ann Dermatol Venereol 1990; 117: 181-184.
24. Kroon S, Clemmensen OJ, Hastrup N. Incidence of congenital melanocytic nevi in newborn babies in Denmark. J Am Acad Dermatol 1987; 16: 788-792.
25. Lorenz S, Maier C, Segerer H, Landthaler M, Hohenleutner U. Skin changes in newborn infants in the first 5 days of life. Hautarzt 2000; 51: 396-400.
26. Berg P, Lindelof B. Congenital melanocytic naevi and cutaneous melanoma. Melanoma Res 2003; 13: 441-445.
27. Zina G, Bundino S, Ubertalli S, Gavinelli R. Studio clinico-evolutivo dei nei congeniti su di un campione di 3073 neonati. G Ital Dermatol Venereol 1985; 120: 5-15.
28. Valiukeviciene S, Miseviciene I, Gollnick H. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania. Arch Dermatol 2005; 141: 579-586.
29. Synnerstad I, Nilsson L, Fredrikson M, Rosdahl I. Frequency and distribution pattern of melanocytic naevi in Swedish 8-9-year-old children. Acta Derm Venereol 2004; 84: 271-276.
30. Garcia Moran JI, Jarabo Garcia MT. Congenital melanocytic nevi: A study of 23 cases in a health center. An Esp Pediatr 1996; 44: 545-547.
31. Handa S, Kaur I. Vitiligo: Clinical findings in 1436 patients. J Dermatol 1999; 26: 653-657.
32. Howitz J, Brodthage H, Schwartz M, Thomsen K. Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark. Arch Dermatol 1977; 113: 47-52.
33. Seghal VN. A clinical evaluation of 202 cases of vitiligo. Cutis 1974; 14: 439-445.
34. Koranne RV, Seghal VN, Sachdeva KG. Clinical profile of vitiligo in North India. Indian J Dermatol Venereol Leprol 1986; 52: 81-82.
35. Mehta NR, Shah KC, Theodore C, Vyas V, Patel A. Epidemiological study of vitiligo in Surat area, South Gujarat. Indian J Med Res 1973; 61: 145-154.
36. Das S, Majumder P, Chakraborty R, Majumdar TK, Haldar B. Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 1985; 2: 71-78.
37. Naldi L, Colombo P, Placchesi EB, Piccitto R, Chatenoud L, La Vecchia C, PraKtis Study Centers. Study design and preliminary results from the pilot phase of the PraKtis study: Self-reported diagnoses of selected skin diseases in a representative sample of the Italian population. Dermatology 2004; 208: 38-42.
38. Koga M, Tango T. Clinical features and course of type A and type B vitiligo. Br J Dermatol 1988; 118: 223-228.
39. Mason CP, Gawkrodger DJ. Vitiligo presentation in adults. Clin Exp Dermatol 2005; 30: 344-345.
40. Boisseau-Garsaud AM, Saint-Cyr I, Quist D, Arveiler B, Garsaud P. Familial aggregation of vitiligo in the French West Indies (Isle of Martinique). Eur J Dermatol 2001; 11: 554-556.
41. Barona MI, Arrunàtegui A, Falabella R, Alzate A. An epidemiologic case-control study in a population with vitiligo. J Am Acad Dermatol 1995; 33: 621-625.
42. Dogra S, Parsad D, Handa S, Kanwar AJ. Late onset vitiligo. a study of 182 patients. Int J Dermatol 2005; 44: 193-196.
43. Handa S, Dogra S. Epidemiology of childhood vitiligo: A study of 625 patients from north India. Pediatr Dermatol 2003; 20: 207-210.
44. Kovacs SO. Vitiligo. J Am Acad Dermatol 1998; 38: 647-666.
45. Zauli D, Tosti A, Biasco G et al. Prevalence of autoimmune atrophic gastritis in vitiligo. Digestion 1986; 34: 169-172.
46. Frati R, Frati C, Sassano PP, Antonaci A. Vitiligo, autoimmune thyroiditis: A rare thyroid cancer arising with bone metastases on maxillofacial area. J Exp Clin Cancer Res 1999; 18: 85-87.
47. Hagedus L, Heidenheim M, Gervil M, Hjalgrim H, Hoier-Madsen M. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol 1994; 74: 120-123.
48. Iacovelli P, Sinagra JL, Vidolin AP et al. Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo. Dermatology 2005, 26-30.
49. Mandry RC, Ortiz LJ, Lugo-Somolinos A, Sanchez JL. Organ-specific autoantibodies in vitiligo patients and their relatives. Int J Dermatol 1996; 35: 18-21.
50. Schallreuter KU, Lemke R, Brandt O et al. Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 1994; 188: 269-275.
51. Kakourou T, Kanaka-Gantenbein C, Papadopoulou A, Kaloumenou E, Chrousos GP. Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo. J Am Acad Dermatol 2005; 53: 220-223.
52. Zettinig G, Tanew A, Fischer G, Mayr W, Dudczak R, Weissel M. Autoimmune diseases in vitiligo: Do anti-nuclear antibodies decrease thyroid volume? Clin Exp Immunol 2003; 131: 347-354.
53. Betterle C, Caretto A, De Zio A et al. Incidence and significance of organ-specific autoimmune disorders (clinical, latent or only autoantibodies) in patients with vitiligo. Dermatologica 1985; 171: 419-423.